Intensity-Modulated Radiation Therapy News 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Hitachi and MD Anderson to investigate IMPT versus IMRT for oropharyngeal cancer
Japanese-based Hitachi's subsidiary Hitachi Healthcare Americas has signed an agreement to collaborate with the University of Texas MD Anderson Cancer Centre to evaluate the intensity-modulated proton beam therapy (IMPT) in a clinical trial for oroph … (Source: Drug Development Technology)
Source: Drug Development Technology - June 8, 2017 Category: Pharmaceuticals Source Type: news
MD Anderson and Hitachi to collaborate in research for treatment of oropharyngeal cancer of the head and neck
(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center and Hitachi Healthcare Americas Corporation, have today announced that they have entered into an agreement to collaborate on research for a unique randomized clinical trial comparing the outcomes and side-effects of intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for the treatment of oropharyngeal cancer of the head and neck. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 7, 2017 Category: International Medicine & Public Health Source Type: news
New Data Reinforce Benefits of TomoTherapy(R) Platform for Mainstream Radiation Therapy Treatment Indications
Multiple Studies Presented at ESTRO 36 Demonstrate System Improves Tumor Control withReduced Toxicities
SUNNYVALE, Calif., May 11, 2017 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) announced today that studies contin... Devices, Oncology Accuray, TomoTherapy, radiotherapy, IMRT (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 11, 2017 Category: Pharmaceuticals Source Type: news
New Varian Cancer Treatment Platform Draws Large Crowds at ESTRO 36 Tradeshow
Unveiled on show floor, Halcyon simplifies and enhances image-guided volumetric IMRT
PALO ALTO, Calif. and VIENNA, May 8, 2017 -- (Healthcare Sales & Marketing Network) -- In front of a large crowd at the annual meeting of the European Society for Radi... Devices, Oncology Varian Medical Systems, Halcyon System, IMRT, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 8, 2017 Category: Pharmaceuticals Source Type: news
Should IMRT Be the New Standard in Esophageal Cancer?
This video discusses the use of intensity-modulated radiation therapy and whether it should be the new standard for treating patients with esophageal cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 3, 2017 Category: Cancer & Oncology Authors: Steven H. Lin, MD, PhD Tags: Videos Gastrointestinal Cancers Source Type: news
IMRT vs Proton Therapy in Esophageal Cancer
This video reviews the advantages and disadvantages of IMRT and proton therapy for the treatment of esophageal cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 3, 2017 Category: Cancer & Oncology Authors: Steven H. Lin, MD, PhD Tags: Videos Gastrointestinal Cancers Source Type: news
Select Mesothelioma Patients Still Benefit from EPP Surgery
The controversial extrapleural pneumonectomy (EPP) surgery should remain a viable option for select patients with malignant mesothelioma, despite a growing reluctance today among thoracic surgeons to recommend the procedure.
When combined with intensity modulated radiation therapy (IMRT), the EPP still can benefit some patients and improve survival times significantly, according to a recent study at the Baylor Scott & White Medical Center in Temple, Texas.
The retrospective look at 18 patients who underwent the EPP/IMRT combination found an average, overall survival rate of 38.2 months and a median relapse-free surviva...
Source: Asbestos and Mesothelioma News - April 17, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: extrapleural pneumonectomy intensity modulated radiation therapy mesothelioma life expectancy mesothelioma surgery mesothelioma survival rates Source Type: news
Big Difference in Early Adoption of Radiotherapy Modalities for Prostate Cancer Big Difference in Early Adoption of Radiotherapy Modalities for Prostate Cancer
The rates of early adoption of intensity-modulated radiotherapy (IMRT) and stereotactic body radiation therapy (SBRT) for older men with prostate cancer differ markedly, according to an analysis of data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare database.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - April 4, 2017 Category: Radiology Tags: Hematology-Oncology News Source Type: news
Intensity modulated pelvic radiation therapy reduces patient reported toxicities
(NRG Oncology) NRG Oncology investigators report better patient-reported quality of life measures for women who received intensity modulated radiation therapy (IMRT) for their pelvic radiation therapy (RT) than those who received standard RT. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 3, 2016 Category: Cancer & Oncology Source Type: news
IMRT associated with reduction in patient reported xerostomia
(NRG Oncology) A pooled analysis of data from NRG Oncology studies RTOG 0129 and 0522 compared intensity-modulated radiotherapy (IMRT) with three-dimensional conformal radiotherapy for patients treated for locally advanced head and neck squamous cell carcinoma. The study found that IMRT was associated with significantly reduced xerostomia and feeding tube dependency after treatment, especially in oropharyngeal cancer patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 3, 2016 Category: Cancer & Oncology Source Type: news
ASCO releases updated breast RT guideline
The American Society of Clinical Oncology (ASCO) has released an updated guideline...Read more on AuntMinnie.comRelated Reading:
New treatment guidelines issued for DCIS
ASCO BCS: Breast MRI useful for average-risk women, too
ASCO BCS research highlights benefits of mobile mammo, PET/MR
ASTRO publishes guidelines for accelerated whole-breast RT
IMRT reduces skin toxicity symptoms for breast cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 29, 2016 Category: Radiology Source Type: news
Is IMRT for Gynecologic Cancers Less Toxic? Is IMRT for Gynecologic Cancers Less Toxic?
Pelvic IMRT reduces acute patient-reported toxicity compared to standard pelvic radiation therapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 28, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Link between facility volume, radiation outcomes for head and neck cancers
The association between provider case volume and outcomes has long been suggested in cancer care. A research team has completed a review of outcomes for patients with locally advanced squamous cell head and neck cancers treated with intensity-modulated radiation therapy (IMRT) and found a distinct association between higher-volume treatment centers and improved overall survival. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 27, 2016 Category: Science Source Type: news
Accuray touts 5-year CyberKnife data in prostate cancer trial
Accuray (NSDQ:ARAY) today released 5-year data from a study of its CyberKnife stereotactic body radiotherapy device for treating prostate cancer, touting a 97% rate of freedom from cancer after treatment at 5-years.
Results from the study were presented at the American Society for Therapeutic Radiology and Oncology’s annual meeting in Boston.
The 21-site, 309-patient trial looked to examine whether dose-escalated SBRT can be administered across multiple institutions without grade 3+ toxicities exceeding 10%. The study followed patients for 5 years and reported toxicity, survival and relapse-free survival outcomes.
At 5 ...
Source: Mass Device - September 26, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Oncology Radiosurgery Accuray Inc. Source Type: news
Postop IMRT Reduces Bowel Obstruction in GYN Cancer (CME/CE)
(MedPage Today) -- Women with BMIs>30 less likely to develop bowel obstruction (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 23, 2016 Category: Hematology Source Type: news
